Related Experiment Video

Updated: Nov 10, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.8K

Insight Into the Prospects for RNAi Therapy of Cancer

Zhili Tian1,2, Guohui Liang1,2, Kunli Cui3

  • 1Institute of Molecular Medicine, Henan University, Kaifeng, China.

Frontiers in Pharmacology
|April 2, 2021
PubMed

Insights

RNA interference (RNAi) offers potential for treating diseases like cancer and COVID-19 by silencing genes. Enhancing delivery systems and reducing side effects are key to improving RNAi therapy effectiveness.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Background:

  • RNA interference (RNAi), or gene silencing, is a natural process with therapeutic potential for diseases like cancer.
  • Current RNAi therapies face challenges in drug delivery to target sites and managing toxic side effects in non-cancerous cells.

Purpose of the Study:

  • To review the mechanism and applications of RNAi, focusing on its role in cancer and COVID-19 treatment.
  • To explore current challenges in RNAi therapy, including delivery systems and drug information for improvement.

Main Methods:

  • Literature review of RNAi mechanisms, applications, and delivery systems.
  • Analysis of challenges in RNAi therapy, particularly for cancer treatment.
  • Identification of advanced delivery systems like lipid-based systems and exosomes.

Main Results:

  • RNAi demonstrates promise in genetic therapies for cancer and has been explored for COVID-19 treatment.
  • Delivery systems, such as lipid-based nanoparticles and exosomes, have significantly improved RNAi therapy by reducing immunogenicity and enhancing cellular uptake.
  • Overcoming delivery and toxicity challenges is crucial for realizing the full potential of RNAi therapies.

Conclusions:

  • RNAi holds significant therapeutic promise, but effective delivery and reduced toxicity are critical for clinical success.
  • Advanced delivery systems are revolutionizing RNAi therapy, improving its safety and efficacy.
  • Further research into RNAi mechanisms and delivery is essential for developing novel treatments for cancer and other diseases.
Keywords:
RNAicancerdelivery systemsexosomesnanoparticles

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.1K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

831

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.0K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K